Revadix
PrivateLast Round
Seed
Apr 11, 2025
Company Overview
Revadix operates in Healthcare & Life Sciences and is based in Toulouse. Its latest recorded funding round was a Seed round in April 2025.
Revadix is a biotechnology company developing small molecule therapies targeting the EPAC-1 protein to treat atrial fibrillation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Revadix Comparables
Compare Revadix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NovaRhythm Biosciences | 83% | |
| Acesion Pharma | 80% | |
| XYRA LLC | 78% |
For institutional investors. Book with your work email.
Revadix Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Revadix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NLC Health Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 11, 2025
Seed round led by NLC Health Ventures.
For institutional investors. Book with your work email.
Revadix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Revadix's valuation, stock price, and market status.
Is Revadix a public or private company?
Revadix is a private company.
What is the current stock price of Revadix?
Revadix is a private company, so its shares have no public market price. Caplight tracks Revadix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Revadix worth (valuation)?
Valuation information for Revadix is not publicly available.
Can I buy Revadix stock?
Revadix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Revadix's last funding round?
Revadix's most recent funding round was Seed on April 11, 2025.
Who are the main investors in Revadix?
Key investors in Revadix include NLC Health Ventures.
Will Revadix IPO soon?
No public IPO plans have been announced for Revadix.
How can I track Revadix secondary market activity?
Caplight tracks bids, offers, and trades in Revadix's shares on secondary markets.